Kirsty Le Doare, MD, PHD Dr. Kirsty Le Doare is a Bill and Melinda Gates Foundation and National Institute for Health Research funded Future Leaders Fellow working between the UK and Uganda. She has over 15 years of clinical and research experience in childhood infection. She completed her undergraduate medical training and paediatric academic training in London, UK. During her PhD she investigated Group B Streptococcal functional antibody in blood and breastmilk and its role in protection against infant colonisation in the Gambia using a novel complement deposition assay.She leads a neonatal immunology network, an international network of clinicians and scientists working together in neonatal GBS that extends to 12 countries worldwide.She is currently leading a Bill and Melinda Gates Foundation funded international collaboration to standardize assays to measure antibody against GBS with the aim of facilitating the development of an immune correlate of protection against GBS colonization and disease. Her main research interests are age-related immune responses to infectious diseases, in particular to Group B-streptococcus (GBS) in neonates and maternal vaccination.She is involved in pre-clinical vaccine development, multi-centre clinical trials and infectious diseases epidemiology research in the UK and in Africa.